Since CGRP has a potent vasodilatator effect throughout the vascular system [40], the chronic inhibition of CGRP pathway with MoAbs and has been considered dangerous because potentially able to induce hypertension and facilitate the precipitation of coronary or cerebral hypoperfusion into ischemia [41, 42]. This evidence concerns the gene CALCA and ischemia.